Terumo Medical’s SurTract Safety Syringe Makes its U.S. Debut

Terumo Medical Corporation has begun the U.S. launch of its SurTract Safety Syringe, powered by SafeR passive safety technology developed by Roncadelle Operations S.r.l. The company will distribute the SurTract Syringe across hospitals, clinics, and emergency-care settings this quarter.

“The SurTract Syringe combines Terumo’s clinical know-how with Roncadelle’s validated SafeR technology to deliver a simple, effective solution for safer injections,” Terumo Medical Vice President Bob Klock said. “It gives healthcare providers more and better treatment options for their patients, which is our ultimate goal.”

SafeR technology provides the SurTract Syringe with a fully passive, automatic retraction mechanism that withdraws the needle into the plunger immediately after use, helping reduce the risk of needle-stick injuries for physicians, and providing patients with a smooth and comfortable injection due to less plunger pressure.* The syringe system also preserves standard clinical technique while offering enhanced safety, reliability and ease of use.

Other benefits include:

• A customizable needle selection designed for use exclusively with SurTract Syringes, allowing physicians the opportunity to create the combination they need for optimal patient care.
• A blunt needle, preventing dullness and allowing a change of needle for drawing up aspiration.
• Less medical waste due to a lack of an external plastic safety sheath.
• Reduction in medication waste due to the low dead space syringe.*

“Terumo has significantly advanced injection safety with the integration of our SafeR technology,” Roncadelle Operations Chief Business Development Officer Dr. Fred Metzmann stated. “Together, we are delivering a next-generation syringe system that is intuitive, reliable, and engineered to protect healthcare professionals.”

Terumo is a global medical innovation company founded in Tokyo in 1921. It provides solutions in therapeutic procedures, hospital operations, and life sciences in more than 160 countries and regions.

Roncadelle Operations S.r.l., headquartered in Brescia, Italy, develops and manufactures advanced medical devices, components, and pharmaceutical packaging. Its proprietary SafeR product line includes passive safety syringes and passive needle-guard systems for pre-filled syringes, designed for safe injection and smart protection in clinical environments. All products comply with ISO 11040-7 and ISO 23908 and are U.S. Food and Drug Administration 510(k)-cleared. As a trusted CDMO partner to global pharmaceutical and medical-device companies, Roncadelle integrates precision molding, automated assembly, and packaging under cleanroom conditions to ensure consistent quality, full traceability, and scalable manufacturing capacity.